RT Journal Article
SR Electronic
T1 Disentangling the shared genetics of ADHD, cannabis use disorder and cannabis use and prediction of cannabis use disorder in ADHD
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.02.22.24303124
DO 10.1101/2024.02.22.24303124
A1 Nielsen, Trine Tollerup
A1 Duan, Jinjie
A1 Levey, Daniel F.
A1 Bragi Walters, G.
A1 Johnson, Emma C.
A1 Thorgeirsson, Thorgeir
A1 ,
A1 Werge, Thomas
A1 Mortensen, Preben Bo
A1 Stefansson, Hreinn
A1 Stefansson, Kari
A1 Hougaard, David M.
A1 Agrawal, Arpana
A1 Gelernter, Joel
A1 Grove, Jakob
A1 Børglum, Anders D.
A1 Demontis, Ditte
YR 2024
UL http://medrxiv.org/content/early/2024/02/24/2024.02.22.24303124.abstract
AB Cannabis use disorder (CUD) and cannabis use (CU) are prevalent conditions cooccurring with ADHD, but not much is known about the underlying shared genetics. Here we perform cross-disorder GWAS meta-analyses of ADHD and CUD or CU to identify pleiotropic risk loci and evaluate differences in the genetics of ADHD-CUD and ADHD-CU, and subsequently we dissect the polygenic architecture of CUD comorbidity in ADHD in the iPSYCH cohort.There was a higher genetic overlap of ADHD and CUD than observed for ADHD and CU and we found a significant direct effect of ADHD genetic risk on CUD with only a minor part (12%) mediated by the genetics of CU. We identified 36 genome-wide significant loci for ADHD-CUD and 10 loci for ADHD-CU, with concordant direction of effect on the phenotypes. Three different approaches identified DRD2, which encodes the dopamine 2 receptor, as a risk gene for ADHD-CUD and, overall, ADHD-CUD risk genes were associated with high expression across several brain tissues and brain developmental stages, which was not observed for ADHD-CU genes. ADHD-CUD and ADHD-CU demonstrated similar genetic correlations with substance use phenotypes, while they differed significantly with respect to substance use disorder (SUD) phenotypes. ADHD-CUD individuals had significantly increased polygenic score (PGS) for psychiatric disorders compared to ADHD without CUD and increased burden of rare deleterious variants. Stratifying individuals with ADHD by their CUD-PGS revealed an absolute risk of 22% for comorbid CUD among the 20% of cases with the highest CUD-PGS, which was strikingly higher than the absolute risk of 1.6% observed among the 20% of controls with the highest CUD-PGS. Sex-specific analyses identified substantial differences in the absolute risk of comorbid CUD between males and females with ADHD, with a ∼10% higher CUD risk among males than females in the high-risk CUD-PGS group (24% risk for males and 14% risk for females).Competing Interest StatementDD has received speaker fee from Medice Nordic. JoG is paid for editorial work for the journal Complex Psychiatry. The remaining authors declare to have no competing interests.Funding StatementD.D. is supported by the Novo Nordisk Foundation (NNF20OC0065561 and NNFC for Genomic Mechanisms of Disease - NNF21SA0072102), the Lundbeck Foundation (R344-2020-1060) the European Unions Horizon 2020 research and innovation programme under grant agreement No. 965381(TIMESPAN). D.F.L. is supported by a Career Development Award CDA-2 from the Veterans Affairs Office of Research and Development (1IK2BX005058-01A2). We acknowledge support from VA Merit Award CX001849-01 (Jo.G.). E.C.J. was supported by NIDA (K01DA051759). The iPSYCH team was supported by grants from the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003), NIH/NIMH (1U01MH109514-01 and 1R01MH124851-01 to A.D.B.) and the Universities and University Hospitals of Aarhus and Copenhagen. The Danish National Biobank resource was supported by the Novo Nordisk Foundation. High-performance computer capacity for handling and statistical analysis of iPSYCH data on the GenomeDK HPC facility was provided by the Center for Genomics and Personalized Medicine and the Centre for Integrative Sequencing, iSEQ, Aarhus University, Denmark (grant to A.D.B.). A.D.B. was also supported by the EUs HORIZON-HLTH-2021-STAYHLTH-01programme, project number 101057385: Risk and Resilience in Developmental Diversity and Mental Health (R2D2-MH). 23andMe data was included in the MDD summary statistics used in this study, we would like to thank the research participants and employees of 23andMe, inc. for making this work possible. This publication does not represent the views of the Department of Veteran Affairs or the United States Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the local scientific ethics committees and IRBs. The iPSYCH study was approved by the Scientific Ethics Committee in the Central Denmark Region (Case No 1-10-72-287-12) and the Danish Data Protection Agency. In accordance with Danish legislation, the Danish Scientific Ethics Committee has, for this study, waived the need for specific informed consent in biomedical research based on existing biobanks.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe summary statics of ADHD-CUD and ADHD-CU are available for public download from https://ipsych.dk/en/research/downloads. All relevant iPSYCH data are available from the authors after approval by the iPSYCH Data Access Committee and can only be accessed on the secured Danish server (GenomeDK, https://genome.au.dk) as the data are protected by Danish legislation. For data access please contact D.D. or A.D.B.